EP 3519008 A4 20200826 - MECHANICAL CIRCULATORY SUPPORT DEVICE WITH AXIAL FLOW TURBOMACHINE OPTIMIZED FOR HEART FAILURE AND CARDIO-RENAL SYNDROME
Title (en)
MECHANICAL CIRCULATORY SUPPORT DEVICE WITH AXIAL FLOW TURBOMACHINE OPTIMIZED FOR HEART FAILURE AND CARDIO-RENAL SYNDROME
Title (de)
MECHANISCHE KREISLAUFUNTERSTÜTZUNGSVORRICHTUNG MIT AXIALSTRÖMUNGSTURBOMASCHINE MIT OPTIMIERUNG FÜR HERZINSUFFIZIENZ UND HERZ-NIEREN-SYNDROM
Title (fr)
DISPOSITIF DE SUPPORT CIRCULATOIRE MÉCANIQUE AVEC TURBOMACHINE À ÉCOULEMENT AXIAL OPTIMISÉE POUR L'INSUFFISANCE CARDIAQUE ET LE SYNDROME CARDIO-RÉNAL
Publication
Application
Priority
- US 201662403428 P 20161003
- US 201762513927 P 20170601
- US 201715619335 A 20170609
- US 2017054573 W 20170929
Abstract (en)
[origin: WO2018067410A1] Mechanical circulatory supports configured to operate in series with the native heart are disclosed. In an embodiment, an intravascular propeller is installed into the descending aorta and anchored within via an expandable anchoring mechanism. The propeller and anchoring mechanism may be foldable so as to be percutaneously deliverable to the aorta. The propeller may have foldable blades. The blades may be magnetic and may be driven by a concentric electromagnetic stator circumferentially outside the magnetic blades. The stator may be intravascular or may be configured to be installed around the outer circumference of the blood vessel. The support may create a pressure rise between about 20-50 mmHg, and maintain a flow rate of about 5 L/min. The support may have one or more pairs of contra- rotating propellers to modulate the tangential velocity of the blood flow. The support may have static pre-swirlers and or de-swirlers. The support may be optimized to replicate naturally occurring vortex formation within the descending aorta.
IPC 8 full level
A61M 60/178 (2021.01); A61M 60/232 (2021.01); A61M 60/33 (2021.01); A61M 60/422 (2021.01); A61M 60/538 (2021.01); A61M 60/822 (2021.01); A61M 60/824 (2021.01); A61M 60/873 (2021.01); A61M 60/876 (2021.01); A61N 1/362 (2006.01)
CPC (source: EP US)
A61M 60/148 (2021.01 - EP); A61M 60/178 (2021.01 - EP US); A61M 60/232 (2021.01 - EP US); A61M 60/33 (2021.01 - EP US); A61M 60/422 (2021.01 - EP US); A61M 60/538 (2021.01 - EP US); A61M 60/808 (2021.01 - EP); A61M 60/812 (2021.01 - EP); A61M 60/814 (2021.01 - EP); A61M 60/822 (2021.01 - EP US); A61M 60/824 (2021.01 - EP US); A61M 60/873 (2021.01 - EP US); A61M 60/876 (2021.01 - EP US)
Citation (search report)
- [XA] US 8690749 B1 20140408 - NUNEZ ANTHONY [US]
- [X] US 2014051908 A1 20140220 - KHANAL SANJAYA [US], et al
- [E] WO 2018209191 A1 20181115 - EDWARDS LIFESCIENCES CORP [US]
- [A] WO 2016097976 A1 20160623 - TAMBURINO CORRADO [IT], et al
- See also references of WO 2018067410A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2018067410 A1 20180412; EP 3519008 A1 20190807; EP 3519008 A4 20200826
DOCDB simple family (application)
US 2017054573 W 20170929; EP 17858942 A 20170929